ID 539 -
Kwas dokozaheksaenowy, Kwas eikozapentaenowy
PL: Kwas dokozaheksaenowy, Kwas eikozapentaenowy
EN: DHA+EPA - long chain omega 3 fatty acids
Pdf: eicosapentaenoic acid
Oświadczenie (2)
- do spełnienia zwiększenie kwasów tłuszczowych omega-3 muszą w czasie ciąży
1. Charakterystyka żywności / składnika
The food constituent that is the subject of the health claims is long-chain n-3 polyunsaturated fatty acids (n-3 LCPUFAs), namely docosahexaenoic acid (DHA) in combination with eicosapentaenoic acid (EPA).
The n-3 LCPUFAs, EPA and DHA, are well recognised nutrients and are measurable in foods by established methods. They are well absorbed when consumed in the form of triglycerides. This evaluation applies to EPA and DHA from all sources with appropriate bioavailability in the specified amounts.
The Panel considers that the food constituent, DHA and EPA, which is the subject of the health claims, is sufficiently characterised.
2.6. Pokrycie zwiększonego zapotrzebowania na kwasy Omega-3 podczas ciąży (ID 539)
The claimed effect is “to fulfil increased omega-3 fatty acids need during pregnancy”. The Panel assumes that the target population is pregnant and lactating women.
The Panel assumes that the claimed effect refers to the supply of omega-3 fatty acids to the body during pregnancy and lactation.
The Panel considers that the claimed effect refers to the supply of a food constituent to the human body, rather than to a relationship between a food/food constituent and health as required by Regulation (EC) No 1924/2006.
Warunki i możliwe ograniczenia stosowania oświadczenia
125 - 500 mg